Zh Nevrol Psikhiatr Im S S Korsakova. 2003;Spec No 2:91-7
146 patients with multiple sclerosis are treated by copaxone in the Moscow MS Centre.
The relaps exacerbation rate decreased by 72%, the relapse rate reduced by 25.6% during the copaxone treatment.
EDSS score did not increase both in group with and without relapses.
The condition of 2/3 patients was stable.
To achieve the best effect of treatment the program of patient support was successfully used in the Moscow MS Centre.